Use of autologous serum in the treatment of ocular surface disorders

Archives of Ophthalmology

Volumn 129, Issue 12, 2011, Pages 1610-1612

  Jeng, Bennie H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD AUTOTRANSFUSION; CLINICAL PRACTICE; CORNEA EPITHELIUM; COST; DIABETES MELLITUS; DRY EYE; EDITORIAL; EYE DISEASE; HEALING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOGLOBULIN DEPOSITION; KERATOCONJUNCTIVITIS; KERATOPATHY; MICROBIAL CONTAMINATION; OCULAR SURFACE DISORDER; PRIORITY JOURNAL; STANDARDIZATION; VIRUS TRANSMISSION; VITRECTOMY;

BLOOD SPECIMEN COLLECTION; CORNEAL DISEASES; DRY EYE SYNDROMES; HUMANS; OPHTHALMIC SOLUTIONS; SERUM;

EID: 83455217812     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.336     Document Type: Editorial

References (40)

1. Ralph RA, Doane MG, Dohlman CH. Clinical experience with amobile ocular perfusion pump. Arch Ophthalmol. 1975;93(10):1039-1043.
2. Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 1984;27(4):459-461. (Pubitemid 14134788)
3. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology. 1999;106(10):1984-1989.
4. Poon AC, Geerling G, Dart JKG, Fraenkel GE, Daniels JT. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol. 2001;85(10):1188-1197. (Pubitemid 32929543)
5. Ferreira de Souza R, Kruse FE, Seitz B. Autologous serum for otherwise therapy resistant corneal epithelial defects - prospective report on the first 70 eyes [in German]. Klin Monbl Augenheilkd. 2001;218(11):720-726. (Pubitemid 33115469)
6. Mukerji N, Sinha R, Vajpayee RB. Role of autologous serum in persistent epithelial defects. Br J Ophthalmol. 2002;86(7):832. (Pubitemid 34713182)
7. Young AL, Cheng AC, Ng HK, Cheng LL, Leung GY, Lam DS. The use of autologous serum tears in persistent corneal epithelial defects. Eye (Lond). 2004;18(6):609-614. (Pubitemid 38961454)
8. Alvarado Valero MC, Martínez Toldos JJ, Borras Blasco J, Almiñana Almiñana A, Pérez Ramos JM. Treatment of persistent epithelial defects using autologous serum application [in Spanish]. Arch Soc Esp Oftalmol. 2004;79(11):537-542.
9. Schrader S, Wedel T, Moll R, Geerling G. Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects. Graefes Arch Clin Exp Ophthalmol. 2006;244(10):1345-1349. (Pubitemid 44463476)
10. Jeng BH, Dupps WJ Jr. Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects. Cornea. 2009;28(10):1104-1108.
11. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol. 1999;83(4):390-395. (Pubitemid 29161176)
12. Rocha EM, Pelegrino FSA, de Paiva CS, Vigorito AC, de Souza CA. GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant. 2000;25(10):1101-1103. (Pubitemid 30303601)
13. Tananuvat N, Daniell M, Sullivan LJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea. 2001;20(8):802-806. (Pubitemid 33029475)
14. Takamura E, Shinozaki K, Hata H, Yukari J, Hori S. Efficacy of autologous serum treatment in patients with severe dry eye. Adv Exp Med Biol. 2002;506(pt B):1247-1250.
15. Ogawa Y, Okamoto S, Mori T, et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant. 2003;31(7):579-583. (Pubitemid 36546837)
16. Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004;88(11):1467-1474. (Pubitemid 39424732)
17. Noble BA, Loh RSK, MacLennan S, et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol. 2004;88(5):647-652. (Pubitemid 38526648)
18. Kojima T, Ishida R, Dogru M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol. 2005;139(2):242-246. (Pubitemid 40288267)
19. Leite SC, de Castro RS, Alves M, et al. Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation. Bone Marrow Transplant. 2006;38(3):223-227. (Pubitemid 44102950)
20. Noda-Tsuruya T, Asano-Kato N, Toda I, Tsubota K. Autologous serum eye drops for dry eye after LASIK. J Refract Surg. 2006;22(1):61-66. (Pubitemid 43172767)
21. Yoon KC, Heo H, Im SK, You IC, Kim YH, Park YG. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol. 2007;144(1):86-92.
22. Lee GA, Chen SX. Autologous serum in the management of recalcitrant dry eye syndrome. Clin Experiment Ophthalmol. 2008;36(2):119-122. (Pubitemid 351445143)
23. Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. 2004;111(6):1115-1120. (Pubitemid 38736990)
24. del Castillo JMB, de la Casa JMM, Sardiña RC, et al. Treatment of recurrent corneal erosions using autologous serum. Cornea. 2002;21(8):781-783.
25. Ziakas NG, Boboridis KG, Terzidou C, et al. Long-term follow up of autologous serum treatment for recurrent corneal erosions. Clin Experiment Ophthalmol. 2010;38(7):683-687.
26. Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea. 2001;20(8):807-810. (Pubitemid 33029476)
27. Schulze SD, Sekundo W, Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am J Ophthalmol. 2006;142(2):207-211. (Pubitemid 44131454)
28. Chen YM, Hu FR, Huang JY, Shen EP, Tsai TY, Chen WL. The effect of topical autologous serum on graft re-epithelialization after penetrating keratoplasty. Am J Ophthalmol. 2010;150(3):352-359, e2.
29. McDonnell PJ, Schanzlin DJ, Rao NA. Immunoglobulin deposition in the cornea after application of autologous serum. Arch Ophthalmol. 1988;106(10):1423-1425.
30. Weisbach V, Dietrich T, Kruse FE, Eckstein R, Cursiefen C. HIV and hepatitis B/C infections in patients donating blood for use as autologous serum eye drops. Br J Ophthalmol. 2007;91(12):1724-1725. (Pubitemid 350207419)
31. Dietrich T, Weisbach V, Seitz B, et al. Manufacture of autologous serum eye drops for out-patient therapy: cooperation between ophthalmic clinic and transfusion medicine department [in German]. Ophthalmologe. 2008;105(11):1036- 1038, 1040-1042.
32. Eberle J, Habermann J, Gürtler LG. HIV-1 infection transmitted by serum droplets into the eye: a case report. AIDS. 2000;14(2):206-207. (Pubitemid 30116449)
33. Maclennan S, Hartwig D, Geerling G. Experiences with a centralised national service for autologous serum eyedrops in England [in German]. Ophthalmologe. 2008;105(7):639-643.
34. Geerling G, Grus F, Seitz B, Hartwig D, Schirra F. Legal regulations to produce serum eye drops: when is it necessary, and how can it be obtained [in German]? Ophthalmologe. 2008;105(7):632-638.
35. Kasper K, Godenschweger L, Hartwig D, Unterlauft JD, Seitz B, Geerling G. On the use of autologous serum eyedrops in Germany [in German]. Ophthalmologe. 2008;105(7):644-649.
36. Lagnado R, King AJ, Donald F, Dua HS. A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol. 2004;88(4):464-465. (Pubitemid 38437859)
37. Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Geerling G. An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol. 2005;243(7):706-714. (Pubitemid 40975497)
38. Bradley JC, Simoni J, Bradley RH, McCartney DL, Brown SM. Time- and temperature-dependent stability of growth factor peptides in human autologous serum eye drops. Cornea. 2009;28(2):200-205.
39. Chiang CC, Chen WL, Lin JM, Tsai YY. Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect. Eye (Lond). 2009;23(2):290-293.
40. Pflugfelder SC. Is autologous serum a tonic for the ailing corneal epithelium? Am J Ophthalmol. 2006;142(2):316-317. (Pubitemid 44107308)